AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3415853 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (2.8 Gy x 15)
Number of subjects: 95
Study 31958656 — intervention group
Group type: EXPERIMENTAL
Intervention: Clover honey
Number of subjects: 37
Study 31958656 — intervention group
Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 37
Study 30409550 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored text messages
Number of subjects: 193
Study 30409550 — intervention group
Group type: EXPERIMENTAL
Intervention: BrainWorks Live
Number of subjects: 193
Study 30409550 — intervention group
Group type: COMPARATOR
Intervention: General text messages
Number of subjects: 193
Study 28855419 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO40 (40 g casein)
Number of subjects: 48
Study 28855419 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO20 (20 g casein)
Number of subjects: 48
Study 28855419 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO20+LEU (20 g casein plus 1.5 g leucine)
Number of subjects: 48
Study 28855419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 25543822 — intervention group
Group type: COMPARATOR
Intervention: Ceramide 2-containing hydrocolloid dressings with varying amounts of tackifying agent (TA)
Number of subjects: 0
Study 25543822 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated applications of ceramide 2-containing hydrocolloid dressings with TA
Number of subjects: 0
Study 22505055 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric endurance exercise
Number of subjects: 45
Study 22505055 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric endurance exercise
Number of subjects: 45
Study 22025591 — intervention group
Group type: COMPARATOR
Intervention: Intubate-Surfactant-Extubate (ISX)
Number of subjects: 648
Study 22025591 — intervention group
Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 648
Study 22025591 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant (PS)
Number of subjects: 648
Study 18682000 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐PDS with contrast enhancement
Number of subjects: 42
Study 18682000 — intervention group
Group type: COMPARATOR
Intervention: 3D‐PDS without contrast enhancement
Number of subjects: 42
Study 18682000 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐PDS
Number of subjects: 42
Study 16284236 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Suction (LBS)
Number of subjects: 11
Study 16284236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 11
Study 16284236 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Arithmetic Task (MAT)
Number of subjects: 11
Study 16284236 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of Muscle Chemoreflex (MCR)
Number of subjects: 11
Study 16284236 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study 12761262 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 690
Study 12761262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study 10669692 — intervention group
Group type: EXPERIMENTAL
Intervention: RCP-directed treatments (Firm A, n = 239)
Number of subjects: 694
Study 10669692 — intervention group
Group type: COMPARATOR
Intervention: Physician-directed treatments (Firms B and C)
Number of subjects: 694
Study 9411036 — intervention group
Group type: EXPERIMENTAL
Intervention: 26-gauge Atraucan
Number of subjects: 100
Study 9411036 — intervention group
Group type: COMPARATOR
Intervention: 27-gauge Whitacre
Number of subjects: 100
Study 9411036 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 8161671 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg
Number of subjects: 245
Study 8161671 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg
Number of subjects: 245
Study 3083519 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH 200 micrograms
Number of subjects: 0
Study 3083519 — intervention group
Group type: COMPARATOR
Intervention: TRH 500 micrograms
Number of subjects: 0
Study 31373524 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Anxiety Learning Modules (CALM)
Number of subjects: 54
Study 31373524 — intervention group
Group type: COMPARATOR
Intervention: CALM-Relaxation only (CALM-R)
Number of subjects: 54
Study 30821830 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal‐external facilitation for 1 year
Number of subjects: 5596
Study 28851443 — intervention group
Group type: EXPERIMENTAL
Intervention: Two approaches to speech and language therapy (SLT)
Number of subjects: 0
Study 28851443 — intervention group
Group type: COMPARATOR
Intervention: No SLT intervention (control)
Number of subjects: 0
Study 26534754 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric MENDs (mechanical external nasal dilators)
Number of subjects: 56
Study 23895315 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Classroom® (RC) approach
Number of subjects: 1561
Study 23895315 — intervention group
Group type: COMPARATOR
Intervention: Fewer RC practices
Number of subjects: 1561
Study 21346062 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary methionine restriction (MR) at 2 mg methionine/kg body weight per day
Number of subjects: 26
Study 21346062 — intervention group
Group type: COMPARATOR
Intervention: Control group with 33 mg methionine/kg body weight per day
Number of subjects: 26
Study 18434580 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental amalgam fillings
Number of subjects: 0
Study 18434580 — intervention group
Group type: COMPARATOR
Intervention: Composite fillings
Number of subjects: 0
Study 17151158 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 1493
Study 17151158 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics (olanzapine, quetiapine, risperidone, ziprasidone)
Number of subjects: 1493
Study 14555296 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosin (DDI) containing regimen
Number of subjects: 116
Study 14555296 — intervention group
Group type: COMPARATOR
Intervention: Non-DDI group
Number of subjects: 116
Study 14555296 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosin (DDI) plus D4T and EFV
Number of subjects: 116
Study 11128915 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable membrane with demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 14
Study 11128915 — intervention group
Group type: COMPARATOR
Intervention: Bioabsorbable membrane without demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 14
Study 11128915 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (with and without DFDBA)
Number of subjects: 14
Study 9069293 — intervention group
Group type: COMPARATOR
Intervention: External beam radiation therapy (EBRT) alone (Group 1)
Number of subjects: 120
Study 9069293 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of neoadjuvant combination therapy (LHRH‐agonist + Flutamide) prior to EBRT (Group 2)
Number of subjects: 120
Study 9069293 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy 3 months before, during, and 6 months after EBRT (Group 3)
Number of subjects: 120
Study 9069293 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 8450178 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose L-carnitine (6 gr per day for two weeks)
Number of subjects: 0
Study 3790388 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% halothane
Number of subjects: 30
Study 3790388 — intervention group
Group type: COMPARATOR
Intervention: 70% nitrous oxide in oxygen
Number of subjects: 30
Study 31065837 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led informational-emotional support program (5 face-to-face sessions, educational booklet, 5 phone follow-ups over 10 weeks)
Number of subjects: 80
Study 31065837 — intervention group
Group type: COMPARATOR
Intervention: Routine cares (Control group)
Number of subjects: 80
Study 30149474 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric lavage (GL) with 10 ml/kg of normal saline
Number of subjects: 0
Study 30149474 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gastric lavage)
Number of subjects: 0
Study 30149474 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric lavage (GL)
Number of subjects: 0
Study 30149474 — intervention group
Group type: COMPARATOR
Intervention: Gastric lavage (GL) and Control group
Number of subjects: 0
Study 28598927 — intervention group
Group type: EXPERIMENTAL
Intervention: ANI-guided fentanyl administration
Number of subjects: 50
Study 28598927 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard clinical practice)
Number of subjects: 50
Study 26625940 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty index (FI) increase by 0.01
Number of subjects: 248
Study 26625940 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty defined as FI >= 0.25
Number of subjects: 248
Study 26625940 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty index (FI)
Number of subjects: 248
Study 23930718 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy decompression with autologous iliac crest bone grafting and internal plate fixation (DDF group: 24 patients)
Number of subjects: 48
Study 23930718 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical corpectomy, posterior longitudinal ligament resection, autologous iliac crest bone grafting, and internal plate fixation (CDF group: 24 patients)
Number of subjects: 48
Study 21077016 — intervention group
Group type: EXPERIMENTAL
Intervention: Red colour comparison test
Number of subjects: 101
Study 21077016 — intervention group
Group type: EXPERIMENTAL
Intervention: Green colour comparison test
Number of subjects: 101
Study 21077016 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue colour comparison test
Number of subjects: 101
Study 21077016 — intervention group
Group type: EXPERIMENTAL
Intervention: Any of the 3 colours
Number of subjects: 101
Study 21077016 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 101
Study 18804999 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT recommended patients
Number of subjects: 350
Study 18804999 — intervention group
Group type: COMPARATOR
Intervention: No MDT recommendation
Number of subjects: 350
Study 16611335 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 650
Study 16611335 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 650
Study 14563573 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1224
Study 14563573 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 1224
Study 14563573 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 1224
Study 14563573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1224
Study 11868167 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofibre dressing
Number of subjects: 0
Study 11868167 — intervention group
Group type: COMPARATOR
Intervention: Traditional dressing (ribbon gauze soaked in proflavine)
Number of subjects: 0
Study 8777885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent impulse compression using the AV impulse device (Novamedix Inc.)
Number of subjects: 40
Study 8777885 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy (standard therapy using cool packs)
Number of subjects: 40
Study 8777885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent impulse compression
Number of subjects: 40
Study 8777885 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 40
Study 1678028 — intervention group
Group type: EXPERIMENTAL
Intervention: breastmilk only
Number of subjects: 45
Study 1678028 — intervention group
Group type: COMPARATOR
Intervention: breastmilk plus supplemental fluid
Number of subjects: 45
Study 7116616 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate as a powder
Number of subjects: 42
Study 7116616 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate as a pressurized aerosol
Number of subjects: 42
Study 7116616 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (aerosol and powder)
Number of subjects: 42
Study 7116616 — intervention group
Group type: COMPARATOR
Intervention: Blind microscopy of wiped nasal-smears
Number of subjects: 42
Study 7116616 — intervention group
Group type: COMPARATOR
Intervention: Counting of sneezes after medication
Number of subjects: 42
Study 30105456 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave lithotripsy (SWL)
Number of subjects: 100
Study 30105456 — intervention group
Group type: COMPARATOR
Intervention: Visual cystolitholapaxy (endoscopy group)
Number of subjects: 100
Study 30105456 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SWL and endoscopy)
Number of subjects: 100
Study 29073916 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation before pregnancy
Number of subjects: 1354
Study 25728722 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous chest compressions without interruption for ventilation
Number of subjects: 23600
Study 25728722 — intervention group
Group type: COMPARATOR
Intervention: Interrupted chest compressions with positive pressure ventilations at a ratio of 30:2
Number of subjects: 23600
Study 24168901 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 23
Study 24168901 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotative instruments
Number of subjects: 23
Study 21480950 — intervention group
Group type: EXPERIMENTAL
Intervention: telcagepant 500 mg
Number of subjects: 22
Study 21480950 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study 19838896 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer educational program
Number of subjects: 345
Study 17272359 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control in hypertensives
Number of subjects: 522
Study 17272359 — intervention group
Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 522
Study 15135275 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance
Number of subjects: 42
Study 15135275 — intervention group
Group type: COMPARATOR
Intervention: Surgical navigation
Number of subjects: 42
Study 11696209 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching group (STR) - 40 min, 3 days per week session of thigh and calf muscle stretching exercises for 10 weeks
Number of subjects: 32
Study 11696209 — intervention group
Group type: COMPARATOR
Intervention: Non-stretching group (CON)
Number of subjects: 32
Study 11696209 — intervention group
Group type: EXPERIMENTAL
Intervention: Both STR and CON
Number of subjects: 32
Study 10205986 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8724298 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS in female patients with SLE
Number of subjects: 35
Study 8724298 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS in male patients with SLE
Number of subjects: 35
Study 8724298 — intervention group
Group type: COMPARATOR
Intervention: DHEAS levels in SLE patients
Number of subjects: 35
Study 2180472 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 51
Study 2180472 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 51
Study 7437212 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate hypotension (mean arterial pressure decreased to 55 mm Hg by sodium nitroprusside)
Number of subjects: 30
Study 7437212 — intervention group
Group type: EXPERIMENTAL
Intervention: Normovolaemic haemodilution (23 +/- 2 ml/kg of blood withdrawn, replaced by twice volume with 4% albumin and Ringer lactate solution)
Number of subjects: 30
Study 7437212 — intervention group
Group type: COMPARATOR
Intervention: Control group (blood replacement equal to blood loss)
Number of subjects: 30
Study 31876300 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) trained on maximizing prostate overlap and minimizing registration errors
Number of subjects: 5
Study 31876300 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) variant trained to optimize prostate overlap
Number of subjects: 5
Study 31876300 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) variant trained to optimize registration
Number of subjects: 5
Study 31876300 — intervention group
Group type: COMPARATOR
Intervention: Elastix (open-source deformable registration software)
Number of subjects: 5
Study 30851351 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen (HBO) administered in 30 daily dives at 100% oxygen to a pressure of 2.4 atmospheres absolute for 80 to 90 minutes.
Number of subjects: 100
Study 30851351 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HBO treatment).
Number of subjects: 100
Study 30851351 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen (HBO) group.
Number of subjects: 100
Study 28876301 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure intervention group
Number of subjects: 337
Study 28876301 — intervention group
Group type: COMPARATOR
Intervention: Attention control case management group
Number of subjects: 337
Study 25467852 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 57
Study 25467852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 24552383 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic ambulatory confinement (HAMB; FIO2 = 0.147; PIO2 = 93.8 mm Hg)
Number of subjects: 11
Study 24552383 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic bed rest (HBR; FIO2 = 0.147; PIO2 = 93.8 mm Hg)
Number of subjects: 11
Study 24552383 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxic bed rest (NBR; FIO2 = 0.209; PIO2 = 133.5 mm Hg)
Number of subjects: 11
Study 23198915 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS patients
Number of subjects: 217
Study 23198915 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 217
Study 21156909 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 22
Study 21156909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 16949877 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged wrist flexion (15 min) in symptomatic patients
Number of subjects: 49
Study 16949877 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged wrist flexion (15 min) in symptomatic patients with normal conduction latency (n = 13)
Number of subjects: 49
Study 16949877 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged wrist flexion (15 min) in symptomatic patients with abnormal conduction latency (n = 21)
Number of subjects: 49
Study 16949877 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 36)
Number of subjects: 49
Study 16949877 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of conduction latency with tactile threshold
Number of subjects: 49
Study 16949877 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of conduction latency with 15-min threshold in subpopulation with abnormal conduction latency
Number of subjects: 49
Study 16949877 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation at 2.5 min after flexion
Number of subjects: 49
Study 16290894 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish massage on back, neck, and chest (BNC)
Number of subjects: 0
Study 16290894 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish massage on leg, arm, and face (LAF)
Number of subjects: 0
Study 12039820 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage
Number of subjects: 263
Study 12039820 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mechanical blood conservation)
Number of subjects: 263
Study 9234029 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical eating disorder (n = 14)
Number of subjects: 90
Study 9234029 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical eating disorder (n = 13)
Number of subjects: 90
Study 9234029 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who intentionally omitted or reduced insulin
Number of subjects: 90
Study 9234029 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulimic behaviours
Number of subjects: 90
Study 9234029 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 63)
Number of subjects: 90
Study 8497636 — intervention group
Group type: EXPERIMENTAL
Intervention: Film interpretation
Number of subjects: 120
Study 8497636 — intervention group
Group type: COMPARATOR
Intervention: Teleradiology system interpretation
Number of subjects: 120
Study 3688570 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG anti-cow's milk antibody
Number of subjects: 200
Study 3688570 — intervention group
Group type: EXPERIMENTAL
Intervention: IgE levels
Number of subjects: 200
Study 3688570 — intervention group
Group type: EXPERIMENTAL
Intervention: Food sensitization (food-specific IgE)
Number of subjects: 200
Study 3688570 — intervention group
Group type: EXPERIMENTAL
Intervention: Signs and symptoms of atopic allergy diseases
Number of subjects: 200
Study 3688570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk-specific IgG antibody
Number of subjects: 200
Study 29172715 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring: weekly assessment of transmitted HBP by physicians and treatment adjustment upon office visits
Number of subjects: 444
Study 29172715 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine: online communication instead of office visits to adjust medication using telemonitored HBP
Number of subjects: 444
Study 29172715 — intervention group
Group type: COMPARATOR
Intervention: Control: usual care with office visits and HBP self‐report
Number of subjects: 444
Study 26488126 — intervention group
Group type: EXPERIMENTAL
Intervention: PCC 37.5 iu/kg
Number of subjects: 6
Study 26488126 — intervention group
Group type: EXPERIMENTAL
Intervention: PCC 25 iu/kg
Number of subjects: 6
Study 26488126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 25212580 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual World (VW)
Number of subjects: 32
Study 25212580 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face (F2F)
Number of subjects: 32
Study 22551811 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 μg hemagglutinin (HA) alone
Number of subjects: 60